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Abstract: Osteoarthritis (OA) is a degenerative joint disease that affects the cartilage, 
subchondral bone, and synovial fluid. Risk factors for knee OA include increase 
adiposity, where excess adipose tissue release pro-inflammatory cytokines and 
adipokines, creating a state of chronic inflammation, and leading to the activation of 
matrix metalloproteinases, which facilitate cartilage breakdown. Individuals with knee 
OA experience pain upon walking or standing, decreased range of motion, and loss of 
function in the affected joint. The purpose of this study is to: (1) evaluate the relationship 
of dietary nutrient intakes with quality of life indicators, pain scores, and serum 
biomarkers of inflammation and cartilage degradation in participants with symptomatic 
knee OA (observational) and (2) evaluate the effects of freeze-dried strawberries on 
serum biomarkers of cartilage degradation in participants with symptomatic knee OA 
(intervention). Study participants (n=17) with abdominal obesity and symptomatic knee 
OA completed baseline self-reported dietary records, VAS and ICOAP pain score 
evaluations, HAQ-DI quality of life indicator assessments, and serum blood draws to 
assess biomarkers of inflammation and cartilage degradation. Subjects were then 
randomly assigned to consume 50g of freeze-dried strawberry powder each day or 50g of 
placebo powder in this 26-week, randomized, double-blind, placebo controlled, cross-
over intervention trial. Results of the observational data showed significant inverse 
correlations of soluble fiber with serum MMP-3, total sugar with MMP-8, saturated fat 
with MMP-3, vitamin C with MMP-8, and copper with IL-6.  Results from our 26-week 
cross-over intervention showed freeze-dried strawberry supplementation significantly 
reduced serum concentrations of MMP-3 compared to the placebo. Our study identifies 
intriguing relationships between dietary nutrient intakes and biomarkers of inflammation 
and cartilage degradation by suggesting that a well-balanced diet, with adequate intakes 
of saturated fat, sugar, vitamin C, soluble fiber, and copper, may have a protective role 
against the activation of cartilage degrading enzymes in knee OA. Additionally, 
strawberry supplementation decreased serum MMP-3 concentrations suggesting that 
well-balanced eating habits should also incorporate an array of antioxidant rich foods, 
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 Osteoarthritis (OA) is a degenerative joint disease that affects the articular cartilage, 
subchondral bone, and synovial fluid of weight bearing joints such as the hips, knee, spine, or 
feet. OA causes pain, stiffness in joints, loss of motion, and is classified by the loss of articular 
cartilage.1,2,5 OA affects more than 27 million individuals in the United States.93 Recently, it has 
been estimated that over 14 million Americans have symptomatic knee OA.94 Over the past 
several decades, epidemiological data has associated knee OA with older age, obesity, the female 
population, metabolic syndrome, inflammation, and elevated serum levels of cartilage degrading 
enzymes.13,63,69-74,88,89  The pathological mechanism by which OA develops is both mechanical and 
metabolic. Metabolically, excess adipose tissue releases adipokines and pro-inflammatory 
cytokines that lead to the onset and progression of the disease by creating a state of chronic 
inflammation and activating matrix metalloproteinases (MMP’s) that facilitate cartilage 
breakdown.14,15,27,56 For this reason, one of the biggest contributing factors to knee OA is 
increased adiposity and metabolic syndrome.9,16 Mechanically, excess weight increases force and 
loading of joints which results in a breakdown of articular cartilage, ligaments, and other 
supporting structures.12 As a result, individuals with knee OA experience pain upon walking or 
standing, as well as loss of motion and function in the affected joint. 
 Although previous observational studies have attempted to identify the relationship 
between food and pain, little is known about the correlations that exists between dietary nutrient 
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intakes with pain scores, quality of life assessments, and biological parameters, such as 
inflammation and cartilage degradation, in diagnosed knee OA.112 Epidemiological data from the 
Framingham Study and the Osteoarthritis Initiative suggest that both prevalence of knee OA and 
the pain associated with the condition, are influenced by diet; specifically the intake of total fiber, 
omega-3 polyunsaturated fatty acids (PUFA), and vitamin C.114-116 However, it is unclear as to 
what relationships exist between dietary nutrient intakes (macronutrients, micronutrients, 
antioxidants, phytochemicals) and both symptoms and metabolic dysregulation associated with 
this condition. 
Currently, there is no cure for osteoarthritis. Many of the treatment strategies focus on 
alleviating pain with the use of pharmaceuticals or non-steroidal anti-inflammatory drugs 
(NSAIDS). In addition, weight loss is also commonly recommended as a treatment strategy to 
relieve pain and improve joint function.28 Many studies have evaluated the role of dietary 
polyphenols and their ability to improve endogenous enzyme systems and reduce pain, 
inflammation, and oxidative stress damage in individuals with symptomatic knee OA.75-80 In 
addition, other nutraceuticals such as ginger powder, avocado/ soybean extracts, and omega-3 
fatty acids have also been shown to reduce pain and pro-inflammatory biomarkers associated with 
knee OA.67,82,83  
Strawberries, a popularly consumed berry fruit, are a rich source of soluble fiber, vitamin 
C, folate, tocopherols, carotenoids, and polyphenols.98 The strawberry polyphenolic composition 
has shown to have anti-inflammatory and antioxidant capacities in individuals with diabetes, 
cardiovascular disease, and hypertension. In modulating cardiovascular disease (CVD) risks, 
strawberries reduced low-density lipoprotein (LDL) cholesterol, circulating adhesion molecules, 
and lipid peroxidation in the form of malondialdehyde (MDA). 48,49,100,101,110 However, to date, 
there has not been a preclinical or a clinical study to evaluate the effects of strawberry 
polyphenols on inflammation and cartilage degradation associated with symptomatic knee OA, 
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especially in individuals with characteristic of metabolic syndrome. Thus, this study aims to 
examine the hypothesis that strawberry supplementation will lower serum biomarkers of cartilage 
degradation in participants with knee OA. 
The goal of this study is to identify the relationship of dietary nutrient intakes with pain 
scores, quality of life indicators, and biochemical parameters in participants with symptomatic 
knee OA using a cross-sectional approach with baseline data. Additionally, this study will also 
investigate the relationship of pain scores and quality of life indicators with biochemical 
parameters in our participants. Finally, this study will attempt to identify strawberries as a 
potential alternative treatment method for decreasing serum biomarkers of cartilage degradation 
in participants with symptomatic knee OA. 
The specific aims are to: 
Observational 
1. To examine whether dietary nutrient intakes at baseline are in any way correlated with 
biomarkers of inflammation, biomarkers of cartilage degradation, pain scores, and quality 
of life indicators in participants with symptomatic knee OA 
2. To examine whether biomarkers of inflammation and cartilage degradation at baseline 
are in any way correlated with pain scores and quality of life indicators in participants 
with symptomatic knee OA 
Intervention 
3. To examine the effects of strawberry intervention on biomarkers of cartilage degradation 
by assessing serum levels of nitrite, MMP-3, and MMP-8 in participants with 
symptomatic knee OA 
For the present study, we hypothesize that: 
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1. Total fat and total carbohydrate intakes will be positively correlated with pain scores, 
circulating biomarkers of inflammation, and circulating biomarkers of cartilage 
degradation in subjects with symptomatic knee OA 
2. Total fat and total carbohydrate intakes will be inversely correlated with quality of life 
indicators in subjects with symptomatic knee OA 
3. Micronutrient and antioxidant intakes will be inversely correlated with pain scores, 
circulating biomarkers of inflammation, and circulating biomarkers of cartilage 
degradation in subjects with symptomatic knee OA 
4. Micronutrient and antioxidant intakes will be positively correlated with quality of life 
indicators in subjects with symptomatic knee OA 
5. Pain scores will be positively correlated with circulating biomarkers of inflammation and 
cartilage degradation in subjects with symptomatic knee OA 
6. Quality of life indicators will be inversely correlated with circulating biomarkers of 
inflammation and cartilage degradation in subjects with symptomatic knee OA 
7. Strawberry supplementation will significantly decrease serum concentrations of nitrite, 








REVIEW OF LITERATURE 
 OA is a degenerative joint disease that affects the cartilage, subchondral bone, and 
synovial fluid. OA generally involves weight bearing joints such as the hips, knee, spine, and 
feet.1 OA causes pain, stiffness in joints, and loss of motion which can be debilitating to those 
who suffer from this chronic condition.2 The pathological mechanism in which OA develops 
focuses on the relationship between cartilage, the synovium, and subchondral bone. OA is 
classified by the degradation of articular cartilage found in joints. Previous findings indicated that 
OA results from injury or excessive loading of weight to a joint as the main cause of cartilage 
degradation. However, new research suggests that systemic inflammation and the release of 
cytokines and matrix metalloproteinases may be equally responsible for cartilage degradation.4 In 
addition, evidence has shown that inflammation of the synovium (synovitis) may also contribute 
to the progression of OA.3    
 Among the more than 200 arthritic conditions, OA is the most commonly treated.5 OA 
affects more than 27 million individuals in the United States.93 Recently, it has been estimated 
that over 14 million Americans have symptomatic knee OA.94 Over the last several decades, 
epidemiological data has associated knee OA with older age, obesity, the female population, 
metabolic syndrome, inflammation, and elevated serum levels of cartilage degrading enzymes ( 
Table 1). In addition, family predisposition, potential for injury, and lifestyle also contribute to 
the incidence of OA.11 Likely one of the most significant contributing factors in knee OA is
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excess weight.13 The mechanism that relates obesity to OA is both mechanical and metabolic. 
Mechanically, excess weight increases the forces and loading of joints which results in a 
breakdown of articular cartilage, ligaments, and other supporting structures. In addition, 
decreased muscle strength can also contribute to the degradation of articular cartilage by altering 
the load placed on the joint. Therefore, weak muscles associated with joints can put increased 
stressed on an already compromised joint.12 Metabolically, adipose tissue or fat stores, release a 
number of different molecules such as adipokines (leptin, adiponectin, visfatin, resistin) and 
cytokines interleukin-1 (IL-1β) and tumor necrosis factor-α (TNF-α). In OA, these proteins 
appear to have pro-inflammatory effects and may contribute to both inflammation and the 
progression of the disease. 14,15 Age is attributed as a contributory factor in the development of 
OA due to the decrease in cartilage homeostasis. Over time, chondrocytes do not respond to 
growth factor stimulation which results in a pathological change to the cartilage.10 However, 
given the obesity epidemic in the United States, more individuals under the age of 65 are 
presenting with symptomatic knee OA due to the metabolic contribution.94 For this reason, OA 
warrants future research efforts to identify strategies for prevention and treatment of this chronic 
condition. 
 
I. Obesity, Metabolic Syndrome, and OA 
When assessing the prevalence of OA, it is important to consider two conditions that 
contribute greatly to the onset and progression of this debilitating disease; obesity and metabolic 
syndrome. Overweight and obesity are identified by calculating body mass index (BMI) where a 
person’s weight in kilograms is divided by height in meters squared. A BMI between 25.0 and 
29.9 kg/m2 is classified as overweight and a BMI greater than 30.0 kg/m2 is considered obese.4 As 
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stated, obesity relates to OA not only due to increased mechanical loading on the knee, but also 
excess adipose tissue and the release of adipokines.  
 According to the National Institutes of Health (NIH), metabolic syndrome is a group of 
biochemical and physiological conditions that significantly increase an individual’s risk for heart 
disease and other chronic illnesses such as diabetes, stroke, and cancer.6 To obtain a diagnosis of 
metabolic syndrome, one must present with at least three of five following conditions: (1) 
waistline measuring greater than 35 inches for women and greater than 40 inches for men, (2) 
blood triglycerides greater than or equal to 150 mg/dL, (3) high-density lipoprotein (HDL) 
cholesterol lower than 40 mg/dL for men and lower than 50 mg/dL for women, (4) blood pressure 
measuring equal to or greater than 130/85 mmHg, (5) insulin resistance measured by a fasting 
plasma glucose of greater than or equal to 100 mg/dL.4, 6,7 Of these factors, insulin resistance or 
an impaired response to insulin in cells, appears to be the most significant cause of metabolic 
syndrome.8 Insulin is important not only in glucose homeostasis, but also in the regulation of pro-
inflammatory cytokines. In a study by Jeschke, et al., insulin showed to reduce the plasma 
concentrations of pro-inflammatory cytokines such as interleukin-6 (IL-6), IL-1β, macrophage 
migration inhibition factor (MIF), and TNF-α.9 
The main concept linking metabolic syndrome to OA is insulin resistance, increased 
adiposity, and the presence of inflammation or pro-inflammatory cytokines which upregulate 
inflammation.9,16 In a review conducted by Wang et al., the researchers propose a cluster of 
metabolic abnormalities that relate metabolic syndrome and inflammation to OA: (1) 
dysregulated metabolites, (2) abnormal body composition, (3)  presence of inflammatory 
cytokines and acute-phase proteins, and (4) presence of inflammatory adipokines.17 
 
II. Inflammation and OA 
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 Dysregulated nutrient metabolism, such as altered lipid profiles, have been associated 
with cartilage degradation in OA patients.18,19 As lipid and glucose metabolism become 
dysregulated, an individual’s body composition changes, which may result in an increased 
amount of adipose tissue. As stated previously, adipose tissue acts as an endocrine organ by 
releasing adipokines. Therefore, when more adipose tissue is present, adipocytes release an 
excess of adipokines such as leptin, resistin, visfatin, and adiponectin.15 These adipokines are 
strongly correlated with inflammation in knee OA by activating pro-inflammatory cytokines.20,21  
 Likely the most significant relation between metabolic syndrome and OA is the presence 
of pro-inflammatory cytokines. The three pro-inflammatory cytokines associated with the 
pathogenesis of OA appear to be IL-6, IL-1β, and TNF-α.15 IL-6 is a cytokine produced by cells 
such as T cells, B cells, monocytes, fibroblasts, osteoblasts, keratinocytes, endothelial cells, 
mesangial cells, and tumor cells.22 The inflammatory response and the release of IL-6 is not only 
seen in low grade inflammation, but also in the development of atherosclerosis.26 In addition, 
there is also a strong correlation between inflammatory markers such as highly sensitive C-
reactive protein (hs-CRP), an acute phase protein produced by the liver in response to 
inflammation, and IL-6 in individuals with metabolic syndrome.25 In terms of knee OA, IL-6, has 
been shown to be elevated in both the synovial tissue and chondrocytes, contributing to the onset 
and progression of the disease.23,24  
IL-1β and TNF-α are also two important pro-inflammatory cytokines associated with OA. 
Both IL-1β and TNF-α are produced within the synovium, including the synovial fluid and 
membrane; as well as in chondrocytes, osteoblasts, and mononuclear cells. IL-1β and TNF-α can 
stimulate the production of IL-6, thus contributing to the pro-inflammatory cascade associated 
with these cytokines in OA.24 In addition, IL-1β and TNF-α appear to have a major impact on 
cartilage degradation by stimulating the release a matrix metalloproteinases, enzymes responsible 
for the breakdown of the cartilage matrix.27 
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  MMP’s are a family of proteolytic enzymes found throughout the human body and 
facilitate the breakdown of extracellular matricies.56 In knee OA, several MMP’s, such as MMP-
1, MMP-3, MMP-8, and MMP-13, have been identified as having a significant influence in the 
degradation of articular cartilage in the knee. In particular, MMP-3 or stromelysin-1, is produced 
by chondrocytes and appears to be directly correlated to the disruption of cartilage homeostasis in 
knee OA. MMP-3 facilitates the breakdown of articular cartilage in the knee, which leads to joint-
space narrowing and pain in the affected joint.56 However, MMP’s are not solely responsible for 
the progression of OA, and are greatly influenced by inflammatory cytokines.27,56 There is also 
evidence which suggests that the adipokine leptin may upregulate the expression and amplify the 
production of MMP-3 in chondrocytes.68 Clinical studies have also shown a significant increase in 
IL-1β, MMP-1 and MMP-3 in the synovial fluid of osteoarthritic knees compared to healthy 
controls.57 Therefore, in the presence of adipokines and inflammatory cytokines, there is an 
increased risk for the activation of these cartilage degrading enzymes. 
Similarly, the combination of leptin and pro-inflammatory cytokines, such as IL-1β, is 
capable of producing reactive oxygen species (ROS) and reactive nitrogen species (RNS) which 
further contributes to the progression of OA.20,27 Nitric oxide (NOx) is a RNS produced via 
inducible nitric oxide synthase (iNOS) from the amino acid L-arginine.58 When converted into its 
active form, NOx can trigger inflammation, tissue destruction, and apoptosis.59 NOx has the 
ability to enhance the activity and synthesis of MMP’s as well as inhibit the synthesis of collagen 
and proteoglycans.60,61 In addition, the relationship between NOx, iNOS, and certain pro- 
inflammatory cytokines appears to be synergistic. NOx appears to be activated by IL-1β and 
TNF-α via iNOS. In the presence of these inflammatory cytokines, the enzyme iNOS is 
significantly upregulated leading to the increased production of NOx.62,65 Moreover, NOx appears 
to significantly increased in both serum and synovial fluid in individuals with primary knee OA 
compared to healthy controls.64 
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III. Pain and Knee OA 
 Pain is a commonly assessed and monitored clinical outcome in the pathogenesis and 
management of OA. Pain is the most common symptom associated with knee OA and the focus 
of many treatment remedies.2,28 There are a number of ways to assess pain level associated with 
knee OA: (1) Visual Analog Scale (VAS) for pain, (2) Short-form McGill Pain Questionnaire 
(SF-MPQ), (3) Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP), and (4) 
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC).102,103 Additionally, 
to understand disease state, the Health Assessment Questionnaire Disability Index (HAQ-DI) is 
often used combination with pain score to evaluate the overall functional status of each patient.104 
Epidemiological research studies have suggest a positive correlation of inflammatory biomarkers, 
such as hs-CRP, IL-1β, and TNF-α, with increased pain.105,106  However, to our knowledge, there 
have not been an observational study which evaluates the relationships of pain with biomarkers of 
cartilage degradation, such as serum levels of MMP-3 and MMP-8 in knee OA. 
ICOAP is a series of questions which are divided into two sections and assess intermittent 
pain or pain that comes and goes, and constant pain or pain that is always present. The scale 
quantifies the patient response to each question providing a score from 0 to 4; (0) ‘not at all’ and 
(4) ‘extremely’.107 The VAS pain scale is used to quantify a visual and verbal representation of 
pain by the use of a horizontal or vertical line ruler which is 100mm in length. This self-reported 
pain method allows a participants to rank their pain from 0 (no pain) to 10 (worst pain 
imaginable) and to place a marker perpendicular to the VAS indicator. The pain score is 
quantified by measuring the distance from 0 (no pain) to the marker indicated by the 
participant.103 In addition to assessing pain, it is also important to understand how this condition 
impacts an individual’s quality of life. HAQ-DI is a questionnaire which aims to understand the 
burden of a chronic condition, such as knee OA, on daily activities such as dressing, eating, and 
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walking.104 Utilization of ICOAP, VAS, and HAQ-DI allows a more in-depth understanding into 
how knee OA impacts the individuals suffering from this condition. 
 
IV. Diet and Knee OA 
 According to the Arthritis Foundation, some of the most common treatments for knee OA 
involve physical activity, weight loss, pharmacological treatment, surgery, and the use of knee 
braces or sleeves.28 One factor that must be considered in both onset and progression of OA is 
nutrient intake. Although a well-balanced, nutrient rich diet is a staple for maintaining a healthy 
lifestyle, it is important to consider the role of dietary nutrient composition and dietary intakes of 
naturally occurring phytochemicals, in the prevention and management of chronic conditions 
such as OA.  
A. Dietary Risk Factors 
 Over the past several decades, there have been a number of epidemiological studies 
conducted to identify dietary risk factors for the development of knee OA. Nutrient risk factors 
for knee OA were identified in the early 1990’s with data from the Framingham Study. The 
results from this large cohort study suggests that lower dietary intake of certain micronutrients, 
such as vitamin C, vitamin E, and β-carotene, are positively associated with risk of developing 
knee OA.95,116 Lower intakes of vitamin C and vitamin D have been shown to be more common 
among individuals with knee OA compared to health controls, and associated with increased risk 
of knee OA.117 Similarly, Wang et. al suggest that high consumption of vitamin C-rich fruits is 
associated with a reduction of bone marrow lesions (BML) development in healthy individuals, 
suggesting a potential protective role in the development of knee OA.113 In addition, previous 
research has also found associations between vitamin K intake and knee OA. Lower dietary 
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intakes and serum levels of phylloquinone (vitamin K) have shown a positive association with 
both the development and progression of knee OA.53, 119  
Macronutrient intakes, specifically fat and carbohydrate intake, have also been studied 
for their role in the risk of knee OA. Higher intakes of total energy, carbohydrates, and sugar have 
shown a positive association with the development of BML’s in knee OA.97 Data from the 
Osteoarthritis Initiative identified that an increase in total fat intake resulted in a decrease in joint 
space narrowing after 48 month follow-up. This study also showed an inverse association 
between PUFA intake and joint space narrowing and concluded that there was a significant risk 
of knee OA progression with an increased intake of saturated fats, and a reduced risk among 
those with higher intakes of PUFA and MUFA.118 Additional data analyzed from the 
Osteoarthritis Initiative suggest the prevalence of knee OA is lower among individuals with 
dietary patterns consistent with a Mediterranean diet. The findings of this study suggests that 
diets higher in whole grains, legumes, fruits, vegetables, olive oils, and lean proteins may have a 
protective role against knee OA.114 These studies suggest that dietary nutrient quality may have a 
strong influence on the pathogenesis of knee OA and may have a role in the prevention of this 
chronic condition. 
B. Dietary Nutrient Intakes on Knee OA Symptoms 
Although dietary risk factors have been widely studied in knee OA, very little is known 
about the relationship of normal dietary intakes with symptoms of knee OA, such as pain, 
mobility, and quality of life. Choi et al. conducted a cross-sectional observational study to 
identify the relationship between momentary knee pain and dietary intakes. The results of this 
study indicated that as participants pain increased, so did their energy consumption, specifically 
in total fat and total sugar. This study suggests that as calorie intake increases, pain increases, 
thus contributing to obesity and the progression of knee OA symptoms.112 In a clinical trial 
conducted by Clinton et. al, a whole-food, plant-based diet rich in phytochemicals and low in 
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animal products revealed an improvement in VAS pain scores among individuals with OA 
compared to participants that continued a normal Western diet. The researchers suspect the 
decrease in pain may be due to the nutrient quality of the (whole-food, plant-based) diet which is 
rich in omega-3 fatty acids and fiber.96 Further findings from the Osteoarthritis Initiative, suggest 
that higher fiber intake (approximately 25g each day), was associated with a decrease in 
WOMAC pain score over an 8 year period.115 Although these studies provide some insight to the 
relationship between diet and pain, a gap in the research still exists when evaluating the 
relationship of common dietary nutrient intakes with pain and quality of life indicators. 
C. Polyphenols 
 Polyphenols are naturally occurring compounds or phytochemicals found in an array of 
foods such as fruits, vegetables, spices, nuts, tea and cocoa. As a non-pharmacologic therapy for 
knee OA, a number of polyphenolic compounds have been studied in clinical trials (Table 2). 
Curcumin, the polyphenol derived from the spice turmeric, has been studied in clinical trials, in-
vitro, and in-vivo. For decades, curcumin has been studied for its anti-inflammatory and 
antioxidant capabilities related to prevention and treatment of chronic diseases.42,43 In OA, 
curcumin has shown to reduce expression of inflammatory cytokines, MMP’s, and NOx in-vitro 
and in-vivo.44,45,90 Additionally, curcumin has also been shown to reduce NSAID use by 
approximately 55%, as well as improve VAS pain score in human subjects.76  
 In overweight and obese humans with clinically diagnosed OA, polyphenols found in 
pomegranate juice, passion fruit extract, tart cherry juice, and rosmarinic spearmint tea have 
shown to significantly reduce WOMAC pain scores by an average of 30%, as well as reduce 
inflammation by 15% (measured by hs-CRP) and MMP-13 by 19%.75,78-80 In-vitro studies have 
concluded that polyphenolic compounds such as resveratrol have the ability to inhibit the 
production of inflammatory cytokines and have also been shown to decrease the production of 
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ROS by more than 75%.46 Similarly, green tea catechins decrease the expression of 
cyclooxygenase-2 (COX-2) and iNOS in IL-1β stimulated chondrocytes by 64% and 94%, 
respectively.87 In-vivo, epigallocatechin gallate (EGCG) has demonstrated the ability to reduce 
the expression of the cartilage degrading enzymes MMP-1, MMP-3, MMP-8, and MMP-13, as 
well as the proinflammatory cytokines IL-1β  and TNF-α in osteoarthritic mice.91 (Table 4) 
D. Nutraceuticals 
 An emerging area of research in the field of nutrition and the fight against chronic disease 
is the use of nutraceuticals. In 1989, Dr. Stephen DeFelice coined the term “Nutraceutical” and 
defined it as, “a food (or part of a food) that provides medical or health benefits, including the 
prevention and/or treatment of a disease.92 Many clinical and in-vitro studies have been conducted 
to show the efficacy of nutraceuticals as a treatment option for knee OA (Table 3 and Table 4). 
Ginger has been widely studied for its ability to act as an anti-inflammatory agent by suppressing 
nuclear factor kappa B (NF-KB) and inhibiting iNOS, TNF-α, and IL-1β.66 In overweight and 
obese humans, ginger and burdock root tea have had promising outcomes in treating 
inflammation associated with knee OA by significantly reducing serum levels of CRP, NOx, and 
IL-6.67,81 Other nutraceuticals such as avocado/soybean unsaponifiables (ASU) and omega-3 
PUFA have also shown to significantly improve VAS and WOMAC pain scores, as well as 
reduce NSAID use associated with knee OA.82,83  
 ASU’s are vegetables extracts that do not form into soaps after saponification. The 
remaining oil is highly concentrated containing one part avocado oil and two parts soybean oil. 
ASU consists of phytosterols, fatty acids, fat-soluble vitamins, and alcohols.39 In-vitro studies 
have demonstrated an average decrease of 65% in the IL-6 and prostaglandin E2 (PGE2) 
production among chondrocytes treated with an ASU ratio of 1 part avocado and 2 parts soybean 
(A1S2) (Table 4).40,41  Next,  omega-3 fatty acids are linked to inflammation because of their 
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ability to produce eicosanoids, molecules that regulate inflammation. For example, it is thought 
that high levels of arachidonic acid, an omega-6 PUFA, may translate to cells within the body and 
increase the production of inflammatory eicosanoids, thus increasing inflammation.35 Conversely, 
omega-3 fatty acids such as eicosapentaenoic acid (EPA) and docosahexaenoic (DHA), produce 
eicosanoids with anti-inflammatory properties and may act to inhibit the metabolism of 
arachidonic acid, thus lowering inflammation.35 Studies have shown how supplementation of 
omega-3 fatty acids reduces both inflammation and pain in knee OA.36,37,83 
E. Weight Loss 
 Diet and weight loss may be an effective approach in reducing both pain and 
inflammation associated with OA. In obese individuals with clinically diagnosed knee OA, a low 
calorie diet, approximately 800-1,000 kcal/day, comprising of 15-20% protein, 45-60% 
carbohydrate, and less than 30% fat, showed a significant improvement in WOMAC pain and 
function scores. When combined with 1 hour of exercise, 3 days a week, results showed a 45% 
improvement in WOMAC pain and a 15% reduction in serum IL-6 levels.30 (Table3)  
F. Supplements and NSAID’s 
 In order to treat pain associated with knee OA, the most common initial treatment option 
is the use of pharmaceuticals such as Paracetamol (Tylenol) and NSAIDS.29 However, 
pharmacological therapy only temporarily reduces inflammation associated with pain and does 
not address the underline cause of OA. Two of the most well-known supplements associated with 
the treatment of arthritis are glucosamine and chondroitin. Both glucosamine and chondroitin 
sulfate are naturally formed elements of cartilage and synovial fluid.31 Because these elements 
can be consumed via the diet, they have received much attention as a treatment option for OA.32-
34, 84-86 However, supplementation with these compounds has only been evaluated for pain and 
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joint narrowing. There is insufficient evidence to suggest that glucosamine and chondroitin treat 
the inflammation cascade associated with knee OA.  
 
V. Berries: Strawberries 
A. Composition and Active Compounds 
 Berries, such as strawberries (Fragaria X Ananassa), are a commercially grown fruits 
that contains an array of micronutrients and phytochemicals making them highly bioactive.47 
Every 100g of fresh weight strawberries provide a rich source of dietary fiber, vitamin C, and 
folate, approximately 2g, 59mg, and 24µg, respectively. Strawberries also contain an adequate 
supply of carotenoids, in the form of lutein and zeaxanthin (26mg/ 100g), tocopherols (1mg/ 
100g), and approximately 40 phenolic compounds such as anthocyanins (27mg/ 100g) and 
pelargonidin (25mg/ 100g), providing strawberries with both antioxidant and anti-inflammatory 
capacities.98,99,111 
B. Effects on Oxidative Stress and Inflammation  
Consumption of berry polyphenols have been evaluated in large-scale epidemiological 
studies and shown to have a role in reducing cardiovascular disease risk and incidence of 
cardiovascular events.108,109 In humans, strawberries have been studied for their ability to reduce 
oxidative stress and improve lipid profiles. Clinical research has shown that strawberries, in the 
form of freeze-dried strawberry powder reduces the risk of cardiovascular disease by decreasing 
serum levels of total cholesterol including LDL cholesterol and small LDL particles, as well as 
circulating vascular adhesion molecules (VCAM). 48,49,100 Moreover, strawberries have the ability 
to significantly reduce lipid peroxidation, increase endogenous antioxidant enzymes, and reduce 
oxidative byproducts such as MDA and hydroxnonenol (HNE).49,100,101 In addition, strawberries 
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have displayed anti-inflammatory properties by reducing pro-inflammatory cytokines such as IL-
1β and IL-6, and increasing the anti-inflammatory cytokine interleukin-10 (IL-10) in peritoneal 
macrophages of mice.50,51 The available clinical and in-vivo research shows promising effects of 
strawberries as a measure to prevent or manage chronic disease. However, to our knowledge, 
there has not been a clinical trial to evaluate the effects of strawberries on markers of 
inflammation and cartilage degradation associated with knee OA suggesting a window for novel 
research in this area. 
 
VI: Summary 
 This section provides an overview of the pathophysiology and disease state associated 
with knee OA. Given the metabolic and mechanical attributes of knee OA, successful 
management of OA symptoms, such as pain, should aim to address the metabolic dysregulation, 
such as chronic inflammation and activation of cartilage degrading enzymes. This review outlines 
the dietary risk factors associated with the onset and progression of knee OA, and clearly 
identifies a lack of evidence on the relationships of normal dietary intakes with biomarkers of 
inflammation, biomarkers of cartilage degradation, pain scores, and quality of life indicators. This 
review also highlights the previous research efforts, which focus on potential dietary and nutrient 
approaches to treating knee OA. Polyphenolic compounds from sources such as pomegranate, 
passion fruit, cherry, and rosmarinic spearmint tea have shown promising results in clinical 
studies at reducing pain and inflammation associated with knee OA. However, to our knowledge, 
there has not been a clinical study to evaluate the effects of strawberries on serum biomarkers of 
cartilage degradation in individuals with symptomatic knee OA. The high polyphenolic 
composition of strawberries have promising effects on lowering inflammation, adhesion 
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molecules, and oxidative stress, and deserves further attention as for other chronic conditions 




















Table 1. Summary of Epidemiological Studies Relating Obesity, Metabolic Syndrome, 
and Inflammation to Knee OA 
Study Design 
 
Sample Size Population Characteristics Significant Findings Ref 
Retrospective 
Cohort 
n=1420 Men and women, with or 
without elevated weight, and 
high or low physical activity 
Risk of developing knee OA 





n=1808 Men and women over 18 
years of age with knee and/or 
hip OA 
BMI = 28.3 ± 6.0 kg/m2 
Knee OA associated with old 





n=142 Women without clinically 
diagnosed knee OA or knee 
injury 
BMI (Baseline) = 25.0 ± 5.0 
kg/m2 
Knee OA associated with 
increased weight results in 
elevated bone marrow lesions, 





n=1,764,061 Men and women  ≥ 40 years 
of age without history of 
diagnosed OA 
Knee OA associated with 





n=908 Caucasian women aged 
between the ages of 45 and 64 
 
Knee OA associated with 
increased BMI and higher 





n=403 Men and women aged 45 to 
60 years old with 
asymptomatic diagnosed knee 
OA, who had not previously 
had surgery 
BMI  = 28.5 ± 4.9 kg/m2 
Cartilage degradation in knee 
OA associated with metabolic 
risk factors such as diabetes 
mellitus, high blood pressure, 






Participants age 27 to 75 with 
diagnosed knee OA, known 
anthropometric measurements 
(blood pressure and serum 
lipid levels), and did not have 
diabetes or known elevated 
fasting plasma glucose 
BMI  = 29.7 ± 5.3 kg/m2 
Knee OA associated with 
multiple metabolic syndrome 
risk factors including central 




n=1384 Men and women with or 
without diagnosed knee OA 
Average BMI (Baseline) = 
23.1 ± 3.4 kg/m2 
Incidence of knee OA is 
influenced by glucose 
intolerance and hypertension 







n=105 Men and women age 45 to 70 
with symptomatic knee OA 
Knee OA associated with 
increased levels of MMP-32, 




n=3465 Men and women with 
clinically diagnosed knee OA 
and available serum 
biomarkers of atherosclerosis 
BMI = 26.8 ± 4.0 kg/m2 
Knee OA associated with 
elevated levels of VCAM-15 
and CD40L6 among women 
[88] 
1 IL-6 = Interleukin-6, 2 MMP-3 = Matrix Metalloproteinase-3 (Stromlysin-1), 3 MMP-9 = Matrix 
Metalloproteinase-9 (gelatinase-B), 4 NO = Nitric Oxide (RNS), 5 VCAM-1 = Vascular Cell Adhesion 
Molecule-1 , 6 CD40L = CD40 Ligand 
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Table 2. Summary of Clinical Studies with Polyphenols and Clinically Diagnosed Knee OA 
 
Intervention & Daily Dose 
 
Study Design & 
Sample Size 










(n = 38) 
6 weeks Decrease in WOMAC1 
pain score and serum 
MMP-133  
 
Increase in serum GPx4 
[75] 
Passion Fruit Extract 
 
Extract (150mg) vs. Placebo 
(150mg) 
Randomized, double-
blind control trial 
(n = 33) 
 
60 days Decrease in WOMAC 
pain and physical 
function scores  
 
[80] 
Tart Cherry Juice 
 
Cherry Juice (16oz.) vs. Control 
(16oz.) 
Randomized, double-
blind cross-over trial 
(n = 46) 
 
6 weeks Decrease in WOMAC 
pain and physical 
function scores, decrease 





Theracumin (180mg) vs. 
Placebo (180mg) 
Randomized, double-
blind control trial 
(n = 50) 
 
8 weeks Decrease in VAS6 pain 






C3 Complex (1500mg) vs. 
Placebo (1500mg) 
Randomized, double-
blind control trial 
(n = 40) 
 
6 weeks Decrease serum MDA8, 
Increase in serum SOD9 
and GSH10 
[77] 
Rosmarinic Acid Tea 
 
Rosmarinic Spearmint Tea 
(280mg/ 600mL) vs. Control 
(26mg/ 600mL) 
Randomized, double-
blind control trial 
(n = 46) 
 
16 weeks Increase in QoL11 score, 
decrease in WOMAC 
pain score 
[78] 
1 WOMAC = Western Ontario and McMaster Universities Osteoarthritis Index, 2 MMP-1 = Matrix 
Metalloproteinase-1, 3 MMP-13 = Matrix Metalloproteinase-13, 4 GPx = Glutathione Peroxidase, 5 hs-CRP 
= highly sensitive C-Reactive Protein, 6 VAS = Knee Pain Visual Analog Scale, 7 Non-Steroidal Anti-
Inflammatory Drugs, 8 MDA = Malonedialdehyde, 9 SOD = Superoxide Dismutase, 10 GSH = Glutathione, 









Table 3. Summary of Clinical Studies with Nutraceuticals and Dietary Approaches in 
Clinically Diagnosed Knee OA 
 
Intervention & Daily Dose Study Design & 
Sample Size 





Ginger Powder (1,000mg) vs. 
Placebo (1,000mg) 
Randomized, double-
blind control trial 
(n=100) 
3 months Decrease in serum hs-
CRP1 and NO2  
 
[67] 
Burdock root tea 
 
Burdock Tea (6g/ 450mL) vs. 




6 weeks Decrease in serum MDA3, 
hs-CRP, and IL-64, 














90 days Decrease in NSAID7 








Phytalgic vs. Placebo 
Randomized, double-
blind, parallel groups 
control trial 
(n=81) 
3 months Decrease in WOMAC9 





Glucosamine Sulfate (1500mg) 
vs. Placebo (1500mg) 
Randomized, double-
blind, control trial 
(n=139) 
3 years No changes in joint-space 
width 
Decrease in WOMAC 









blind control trial  
(n=110) 
 
1 year No changes in joint-space 
width 






Glucosamine (1500mg) vs. 
Chondroitin (1200mg) vs. 
Combination (2700mg) vs. 
Celexicob (200mg) vs. Placebo 
Randomized, double- 
blind control trial 
(n=357) 
24 months Glucosamine alone had 
lowest loss in joint-space 





Diet and Exercise 
 
Diet Only (800 to 
1,000kcal/day) vs. Diet & 
Exercise (800 to 1000 kcal/day 
and 3 hours/week of physical 
activity) vs. Exercise Only (3 





18 months Decrease in weight and 
serum IL-6 among diet 
only and diet & exercise 
group 
Decrease in WOMAC 
pain score among diet & 
exercise group  
[30] 
1hs-CRP = highly sensitive C-Reactive Protein, 2 NO = Nitric Oxide, 3 MDA = Malonedialdehyde, 4 IL-6 = 
Interleukin-6, 5 TAC = Total Antioxidant Capacity, 6 SOD = Superoxide Dismutase, 7 NSAID = Non-
Steroidal Anti-Inflammatory Drugs, 8 VAS = Knee Pain Visual Analog Scale,  9 WOMAC = Western 




Table 4. Summary of in-vitro and Animal Studies with Nutraceuticals and Knee OA 
Nutraceutical & Dose Cell/ Animal 
Model 





5µM vs. 10µM vs. 15µM vs. 20µM 
Human 
chondrocytes 
Reduced production of NO1, IL-62, 












Omega-3 Fatty Acids  
 
10 to 100µg/ mL of Omega-3 and 
fatty acid blend 
Bovine 
chondrocytes 
Reduced mRNA expression of Agg-






Avocado Only-(3.3 and 10µg/ mL) vs. 
Soybean Only-(6.6 and 10µg/ mL) vs. 




Reduction in IL-6, NO, and MMP-3 





IL-1β  (5ng/mL) and 100 µg/ mL of 
EGCG10 vs. IL-1β (5ng/mL)  and 200 




Reduction in the activity of iNOS11 
and COX-212, reduction in the 




Oral Curcumin (50mg/kg) vs. Topical 
Curcumin Nanoparticles (0.07mg of 
10µg curcumin/ 1mg nanoparticles) 
vs. Vehicle Control (Coconut Oil) 
C57BL/6 Mice Suppression of  mRNA expression of 
IL-1β, TNF-α, MMP-114, MMP-3, and 
MMP-1315 
Oral administration decreased OA 
disease progression 
Topical nanoparticles decreased 
synovitis and subchondral plate 
thickness, decreased expression of 
adipokines and pro-inflammatory 




Intraperitoneal injection  of EGCG 
(25mg/kg) vs. control vehicle 
C57BL/6 Mice Reduced levels of MMP-1, MMP-3, 
MMP-13, IL-1β, and  TNF-α in 
articular cartilage 
[91] 
1 NO = Nitric Oxide,  2 IL-6 = Interleukin-6, 3 MMP-3 = Matrix Metalloproteinase-3 (Stromylsin-1),  4 IL-
1β = Interleukin-1-beta,  5 ROS = Reactive Oxygen Species, 6 Agg-1 = Aggrecanase-1 , 7 Agg-2 = 
Aggrecanase-2, 8 IL-1α = Interleukin-1-alpha, 9 TNF-α = Tumor Necrosis Factor-alpha,  10 EGCG = 
Epigallocatechin-3-gallate, 11 iNOS = inducible Nitric Oxide Synthase, 12 COX-2 = Cyclooxygenase-2, 13 









 Approval from Oklahoma State University’s International Review Board (IRB) was 
obtained prior to recruitment for this study. Investigators and research assistants involved in this 
study completed training through the Collaborative Institutional Training Initiative (CITI). 
Additionally, all participants provided written consent to the study prior to being enrolled.  
 Participants were recruited from the Oklahoma Medical Research Foundation (OMRF) 
patient registry through recruitment flyers/emails, as well as referrals from the Oklahoma 
University Health Science Center (OUHSC). Subjects included in the study were ambulatory men 
and women (over the age of 18) with an enlarged waist circumference (women >35 inches, men 
>40 inches) and knee pain due to age-related degenerative knee OA (based on medical history 
and baseline questionnaire). Participants stable on hypolipidemic, hyperglycemic, and/or anti-
hypertensive medications were also included in the study. Individuals were excluded from the 
study if they had any type of pre-existing disease such as cancer, coronary heart disease, liver 
failure, or renal disorders. Additionally, participants were also excluded if they were pregnant or 
lactating, had knee surgery, a traumatic knee injury, allergic to strawberries, taking mega doses 
(greater than 1,000mg) or antioxidants or fish oil supplements, recent participation in a weight 
loss program, or those who smoke. After recruitement, 17 subjects were enrolled and completed 




 In a 26-week randomized placebo-controlled crossover trial, participants were 
randomized to either the intervention or placebo group. The intervention group consumed 50 
gram of freeze-dried strawberry powder reconstituted in water each day divided into two doses. 
The placebo group followed an identical protocol consuming 50 grams of placebo powder each 
day divided into two doses. Participants spent 12 weeks in the intervention or placebo arm of the 
study, completed a 2-week washout period, and then crossed over to the opposite arm. The 
freeze-dried strawberry and placebo powder were provided to study participants in vacuum-
sealed packs with storage instructions. 
 
Blood draws and laboratory tests 
Fasting blood samples were collected at baseline, end of week 12 (end of phase 1), week 
14 (end of wash-out), and week 26 (end of phase 2). All patients were seen at the Oklahoma 
Clinical and Translational Science Institute (OCTSI) or at OUHSC, and blood samples were sent 
to OU Medical Center for analyses of glucose, HbA1c, lipid profiles, and hs-CRP. Serum 
collected was separated and stored at -80˚C until analyzed. Serum nitrite levels were assessed 
using Promega Griess Reagent System (Promega Madison, WI) and serum levels of MMP-3, 
MMP-8, IL-6, and IL-1β were assessed using the R&D Human Quantkine ELISA (R&D 
Systems, Minneapolis, MN) immunoassay system.   
 
Dietary Intakes 
All study participants were asked to maintain their usual dietary habits throughout the 
duration of the study. Participants were required to complete a three-day food record to assess 
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normal or common dietary intakes. Dietary intakes were provided by the subjects at baseline, end 
of week 12 (end of phase 1), week 14 (end of wash-out), and week 26 (end of phase 2). Nutrient 
composition was analyzed using Nutritionist Pro Software (Axxya Systems, Redmond, WA). 
 
Pain and Quality of Life Assessments 
Pain scores and quality of life assessments were obtained at baseline, end of week 12 
(end of phase 1), week 14 (end of wash-out), and week 26 (end of phase 2). Knee pain analysis 
was assessed using ICOAP and VAS pain scales. ICOAP is a series of questions which are 
divided into two sections and assess intermittent pain or pain that comes and goes, and constant 
pain or pain that is always present. The scale quantifies the patient response to each question 
providing a score from 0 to 4; (0) ‘not at all’ and (4) ‘extremely’.107 Scores were then normalized 
between 0 (no pain) and 100 (extreme pain). The scores for constant pain (five questions) were 
scored out of 20, while scores for intermittent pain (six questions) were scored out of 24. 
Percentages were then calculated for each participant.  
The VAS pain scale is used to quantify a visual and verbal representation of pain by the 
use of a horizontal or vertical line ruler which is 100mm in length. This self-reported pain method 
allows a participants to rank their pain from 0 (no pain) to 10 (worst pain imaginable) and to 
place a marker perpendicular to the VAS indicator. The pain score is quantified by measuring the 
distance from 0 (no pain) to the marker indicated by the participant.103 Scores were categorized as 
follows: 0-4 (no pain), 5-44 (mild pain), 45-75 (moderate pain), 76-100 (extreme pain). Scores 
were then translated to represent a score between 0 and 3, where 0 indicated no pain and 
increasing scores indicated worsening pain.  
In combination with ICOAP and VAS, HAQ-DI was also utilized to evaluate the health 
state of the participants. HAQ-DI is a questionnaire which aims to understand the burden of a 
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chronic condition, such as knee OA, on daily activities such as dressing, eating, and walking.104 
HAQ-DI questionnaires assess eight domains, allowing a score of 0 (indicating ease with 
performing the task) and 3 (indicating difficulty or inability to perform the task). Total scores are 
calculated into a percentage out of a total possible score of 24. Scores were then normalized 
between 0 (indicating no difficulty with a task) and 100 (indicating severe difficulty or inability 
to perform a task). All non-invasive indicators will contribute to pain score evaluations and the 
association to dietary intakes at baseline. 
 
Statistical analyses 
Observational Study – Baseline Data 
Demographic data, disease characteristics, dietary intakes, serum biochemical markers, 
pain scores, and quality of life assessments were summarized for all study participants at baseline 
and expressed in mean and standard error of the mean. Frequencies were identified from baseline 
data and correlations were expressed using Pearson correlation coefficient. A second model was 
generated to adjusted for total energy intakes with the highest and lowest calories dropped from 
the correlation analysis. 
1. Correlations of dietary nutrient intakes (macronutrient, micronutrient) vs. serum markers 
of inflammation and cartilage degradation (hs-CRP, IL-1β, IL-6, NOx, MMP-3, MMP-8), 
pain scores (ICOAP, VAS), and quality of life indicators (HAQ-DI) 
 
2. Correlation of serum biomarkers of inflammation and cartilage degradation (hs-CRP, IL-






Demographic data, disease characteristics, dietary intakes, serum inflammatory markers, 
pain scores, and quality of life assessments were summarized for all study participants at baseline 
and expressed in mean and standard error of the mean. Change in serum biomarkers of cartilage 
degradation were compared at different time points between the strawberry intervention and 
placebo groups using a PROC MIXED analysis adjusting for baseline measure as a covariate. 
Data was collected at the end of the washout phase; however, since no carryover effects were 
noted, baseline data was used to adjust in the final model. All analyses were conducted using 
Statistical Analysis Software version 9.2 (SAS Institute, Cary, NC). A two sided p-value of less 



































Assessed for Eligibility (n=17) 
Subjects identified with knee OA and abdominal 
obesity 
Excluded (n=0) 
Enrolled in Study (n=17) 
Subjects identified with knee OA and abdominal obesity 
 
Baseline Evaluation: 
Blood Draws, Three Day Food Records, Pain Score 
Assessments, Quality of Life Indicators 
Subjects randomly assigned to crossover study 
Intervention – 12 weeks 
50g of Freeze-Dried Strawberry 
Powder Daily 
 
Placebo – 12 weeks 
50g of Placebo Powder Daily 
 
2 week wash-out period 
Placebo – 12 weeks 
50g of Placebo Powder Daily 
 
Intervention – 12 weeks 
50g of Freeze-Dried 









Nutrient Composition of Freeze-Dried Strawberry Powder 
 A nutrient analysis was completed by the California Strawberry Commission to 
determine the macronutrient composition of the freeze-dried strawberry powder and the placebo 
(Table 5). Freeze-dried strawberry powder (50g) used in our study is equivalent to approximately 
500 grams of fresh weight strawberries (1.10 lb). The analysis indicated that 50 grams of freeze-
dried strawberry powder or placebo powder provided approximately 150 and 180 calories, 
respectively, to each participant’s daily dietary intakes. The overall calorie contribution for each 
macronutrient of the freeze-dried strawberry powder was 88% carbohydrate, 9.3% protein, and 
6% fat. The freeze-dried strawberry powder provided significant amounts of polyphenols and 
anthocyanins, while these phytochemicals were not detectable in the placebo powder.  
 
Baseline Characteristics 
 Anthropometrics, Blood Pressure, Lipid Profiles, Medications 
 The baseline characteristics are summarized in Table 6. Among the 17 participants 
recruited for this pilot study, 4 were male and 13 were female. The age of the participants ranged 
from 45 to 75 years of age, with the mean age being 56.5 years (± 1.7). Additionally, 16 of the 17 
participants were classified as obese, having a BMI greater than 30.0 kg/m2. Each participant 
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presented with an enlarged waist circumference (greater than 35 inches of females and 40 inches 
for males) with the mean size being 46.9 inches (± 1.1). The average blood pressure for all 
participants can be considered normal (<130/85 mm/Hg), however, of our 17 participants, 11 
were taking blood pressure medications at baseline. Other metabolic factors indicated that on 
average, participants had an elevated fasting blood glucose (> 100mg/dL), with 2 participants 
diagnosed with diabetes, and 6 participants being on lipid lowering medications. 
Pain Scores, Quality of Life Indicators, Biochemical Parameters 
 At baseline, study participants, on average, reported mild to moderate pain based on 
ICOAP and VAS scores. ICOAP scores for intermittent pain ranged from 2 to 15 out of a possible 
score of 24, with an average score of 9.2 out of 24 or 38.5%. Constant pain scores ranged from 0 
to 11 out of a possible 20, with an average score of 6.4 or 31.8%. Overall, total ICOAP pain 
ranged from 4 to 26 out of a possible 44, with an average score of 15.6 or 35.4%.  VAS pain 
scores varied from 0.3 (indicating no or little pain) to 2.8 (indicating extreme pain), with an 
average of 1.4 (indicating moderate pain). Finally, HAQ-DI scores reported by the participants 
indicated mild to moderate difficulty performing daily tasks. Scores ranged from 0 to 1.0 with an 
average score of 0.62.  
 Biochemical data also varied among participants. At baseline CRP ranged from 1.5 to 
20.6 mg/L. In addition, a large variation was seen among IL-1β, ranging from 3.1 to 52.4 pg/mL. 
Less variation was seen among IL-6, nitrite, MMP-3, and MMP-8 with serum levels ranging from 
5.3 to 11.8 pg/mL, 3.7 to 11.4 µM, 2.1 to 10.4 ng/mL, and 0.8 to 5.3 ng/mL, respectively. 
Dietary Intakes 
 All dietary data was summarized based on three-day food records provided by the 
participants at baseline. Total calorie intake varied dramatically ranging from 767 kcals per day to 
4,316 kcals per day. Based on calorie contribution for each macronutrient, diets consisted of 
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approximately 42% carbohydrate, 40% fat, and 18% protein, with saturated fat intake accounting 
for 13% of total calories. Participants were consuming a daily average of 67 grams or 5.5 
tablespoons sugar. The average daily fiber intake was 17.7 grams which falls well below the daily 
recommendation of 25 grams per day for women, and 38 grams per day for men.52 In addition, 
dietary intakes among study participants fell short of the Recommended Daily Allowance (RDA) 
for vitamin C (44.7 mg/day compared to the RDA of 75 mg/day), vitamin D (55 IU/day compared 
to the RDA 600 IU/day), vitamin E (4.6 mg/day compared to the RDA 15 mg/day). Finally, 
although there is no set RDA for omega-3 PUFA intake, the designated Adequate Intake (AI) was 
also not met on average by study participants.52 
 
Observational Findings: Correlation Analyses Among Dietary Nutrient Intakes and 
Biomarkers of Pain, Inflammation, and Cartilage Degradation 
 Correlations between variables were identified using baseline data (Table 8, 9, 10) and 
expressed in r-values. Assessment of macronutrient intakes revealed a statistically significant 
moderate inverse relationship of soluble fiber with serum MMP-3 concentrations, total sugar with 
MMP-8, and saturated fat with MMP-3. Upon assessment of micronutrient intakes, a significant 
moderate inverse relationship was identified between vitamin C and MMP-8, as well as between 
copper and IL-6 (p<0.05). 
 Although not statistically significant, there were several trends identified in our data 
worth mentioning. First, VAS pain trended toward a positive relationship with serum IL-1β 
concentrations (p=0.086). Additionally, there was a trend toward an inverse relationship of total 
carotenoids (RE), β-carotene, and vitamin C with serum MMP-3 concentrations (p=0.055, 0.097, 
0.093, respectively).  
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 Due to the variation in participant calorie intake, correlations were also analyzed with all 
nutrients adjusted to 1,000 calories with the highest and lowest total calories excluded from the 
analyzed data (n=15). The results showed a statistically significant inverse correlation between 
HAQ-DI scores and total cholesterol (p=0.024). Additionally, there was a significant positive 
correlation between ICOAP constant pain and total carbohydrate intake (p=0.022). Adjusted 
correlations between nutrients and serum biomarkers revealed inverse relationship of soluble 
fiber with MMP-8 (p=0.030), vitamin C with MMP-8 (p=0.034), and copper with IL-6 (p=0.040).   
 
Intervention Findings: Effects of Freeze-Dried Strawberries on Biomarkers of Cartilage 
Degradation  
 Three parameters were used to assess cartilage degradation and inflammation in the study 
participants (Table 11). After the 12 week strawberry intervention, serum concentrations of the 
cartilage degrading enzyme, MMP-3, was significantly reduced by 18.8% (p<0.05). MMP-8 and 










Table 5. Strawberry Beverage Composition 
 
 Strawberry Placebo 
Serving Size (g) 50.0 50.0 
Calories (kcal) 150.0 180.0 
Fat (g) 1.0 1.0 
Protein (g) 3.5 0.2 
Carbohydrates (g) 33 43.9 
Total Polyphenols (mg) 2006.0 n.d 
Total Anthocyanin (mg) 154.0 n.d 
Phytosterols (mg) 50.0 n.d 
Total dietary fiber (g) 4.0 5.2 
Strawberry powder was obtained through the California Strawberry Commission. (g) = grams; 
















Table 6. Participant Baseline Characteristics1 
(n=17) 
Age (yrs) 56.5 ± 1.7 
Gender (m/f) 4/13 
Height (cm) 169.4 ± 2.8 
Weight (lbs) 244.9 ± 7.2 
BMI (kg/m2) 39.3 ± 1.6 
Waist Circumference (inches) 46.9 ± 1.1 
Systolic BP (mm/Hg) 126.8 ± 2.0 
Diastolic BP (mm/Hg) 81.7 ± 1.3 
Triglycerides (mg/dL) 130.3 ± 13.4 
Total Cholesterol (mg/dL) 187.6 ± 8.9 
HDL (mg/dL) 54.3 ± 3.5 
LDL (mg/dL) 105.5 ± 7.9 
Fasting Glucose (mg/dL) 112.3 ± 5.3 
HbA1C (%) 6.1 ± 0.2 
Blood Pressure Medication (n) 11/17 
Lipid Medication (n) 6/17 
Diagnosed w/Diabetes (n) 2/17 
Vitamin Supplement Use (n) 11/17 
HAQ-DI 0.6 ± 0.1 
VAS : Pain 1.4 ± 0.2 
VAS : Health 0.7 ± 0.1 
ICOAP : Constant Pain Subscale % 31.8 ± 3.5 
ICOAP : Intermittent Pain Subscale % 38.5 ± 3.4 
ICOAP : Total Pain Score % 35.4 ± 3.1 
C-Reactive Protein (mg/L) 5.75 ± 1.2 
Interleukin-6 (pg/mL) 8.85 ± 0.4 
Interleukin-1β (pg/mL) 18.65 ± 4.0 
Serum Nitrite (µM) 6.45 ± 0.8 
MMP-3 (ng/mL) 7.0 ± 0.6 
MMP-8 (ng/mL) 1.85 ± 0.3 
1 values expressed in mean  ± standard error 
(BMI) = Body Mass Index; (m) = Male; (f) = Female; (cm) = Centimeter; (lbs) = Pounds; (kg) = 
Kilogram; (m2) = Meters squared; (yrs) = Years; (mm/Hg) = Millimeters of Mercury; (mg/dL) = 
milligrams per deciliter; (n) = numerical value; (HAQ-DI) = Health assessment questionnaire 
disability index; (ICOAP) = Measure of intermittent and constant osteoarthritis pain; (VAS) = 
Visual analog scale; (mg/L) = milligrams per liter; (pg/mL) = pictograms per milliliter; (ng/mL) = 







Table 7. Baseline Total Dietary Nutrient Intakes1 
(n=17) 
Calories (kcal) 2,026.5 ± 182.7 
Fat Calories (kcal) 807.2 ± 107.4 
Saturated Calories (kcal) 269.8 ± 34.2 
Protein (g) 92.3 ± 11.2 
Carbohydrate (g) 214.6 ± 19.5 
Fiber (g) 17.7 ± 1.9 
Soluble Fiber (g) 0.9 ± 0.2 
Sugar (g)  66.74 ± 5.8 
Fat (g) 89.8 ± 12.0 
Saturated Fat (g) 30.0 ± 3.8 
Monounsaturated Fat (g) 16.9 ± 3.8 
Polyunsaturated Fat (g) 7.9 ± 1.9 
Trans-Fat (g) 1.1 ± 0.4 
Cholesterol (mg) 304.2 ± 53.9 
Vitamin A (IU) 4,130.8 ± 1,134.2 
Carotenoids (RE) 127.4 ± 50.8 
β-Carotene (mcg) 584.7 ± 304.1 
Vitamin C (mg) 44.7 ± 9.0 
Vitamin D (IU) 55.3 ± 14.5 
Vitamin E (mg) 4.6 ± 1.7 
Copper (mg) 0.6 ± 0.1 
Iron (mg) 9.9 ± 1.2 
Zinc (mg) 6.7 ± 1.0 
Omega-3 (g) 0.8 ± 0.3 
1 values expressed in mean  ± standard error 
(kcal) = kilocalories; (g) = grams; (mg) = milligrams; (IU) = International Units; (RE) = Retinol 










Table 8. Pearson’s Correlation1 














Total Caloies (kcal) -0.030 0.373 -0.008 0.025 0.049 0.043 
Protein (g) -0.132 0.275 -0.103 -0.193 -0.102 -0.157 
Total Carbohydrate (g) -0.193 0.385 -0.071 -0.141 -0.005 -0.074 
Total Fiber (g) -0.114 0.342 0.118 -0.138 0.000 -0.069 
Soluble Fiber (g) 0.181 0.332 0.068 0.463 0.276 0.400 
Total Sugar (g) 0.138 0.316 -0.099 0.169 -0.212 -0.038 
Total Fat (g) -0.262 0.176 0.269 -0.244 -0.303 -0.304 
Saturated Fat (g) 0.130 -0.098 0.305 0.178 0.367 0.308 
Monounsaturated Fat (g) -0.132 0.273 -0.102 -0.195 -0.103 -0.159 
Polyunsaturated Fat (g) -0.193 0.385 -0.071 -0.141 -0.005 -0.074 
Trans Fat (g) -0.290 -0.018 0.033 -0.340 -0.110 -0.238 
Cholesterol (mg) -0.307 0.203 -0.062 -0.159 -0.077 -0.126 
Vitamin A (IU) 0.058 0.122 0.200 0.359 0.147 0.270 
Carotenoids (RE) -0.216 0.120 0.386 0.349 0.357 0.389 
Β-carotene (mcg) -0.206 0.082 0.404 0.342 0.369 0.392 
Vitamin C (mg) -0.255 0.164 0.408 0.128 0.100 0.125 
Vitamin D (IU) 0.069 0.055 -0.100 0.028 -0.124 -0.058 
Vitamin E (mg) 0.095 -0.095 -0.135 -0.213 -0.306 -0.288 
Copper (mg) 0.107 0.078 -0.122 -0.091 -0.268 -0.215 
Iron (mg) 0.169 0.387 -0.036 -0.070 -0.166 -0.133 
Zinc (mg) -0.235 0.168 0.109 -0.267 -0.221 -0.239 
Omega-3 PUFA (g) -0.205 -0.155 0.048 -0.377 -0.080 -0.239 
Omega-6 PUFA (g) -0.339 0.188 -0.118 -0.252 -0.133 -0.207 
1 Values expressed in r-values 
*p<0.05 
Bold values indicate possible trends 
 
(kcal) = kilocalories; (g) = grams; (mg) = milligrams; (IU) = International Units; (RE) = Retinol 
Equivalents; (mcg) = micrograms; (IL-6) = Interleukin-6, (IL-1β) = Interleukin-1 beta, (MMP-3) 










Table 9. Pearson’s Correlation1 
Dietary Nutrient Intakes vs. Biochemical Data 
(n=17) 
 CRP IL-6 IL-1β NOx MMP-3 MMP-8 
Total Calories (kcal) -0.127 0.201 0.155 0.299 -0.326 -0.041 
Protein (g) -0.196 0.237 0.021 0.284 -0.197 0.093 
Total Carbohydrate (g) -0.277 0.071 0.043 0.133 -0.228 0.181 
Total Fiber (g) -0.201 -0.056 0.107 -0.055 0.061 0.104 
Soluble Fiber (g) 0.108 0.148 0.296 -0.055 -0.541* -0.316 
Total Sugar (g) 0.150 -0.253 0.160 0.284 -0.141 -0.531* 
Total Fat (g) -0.140 0.089 0.093 -0.112 -0.298 -0.264 
Saturated Fat (g) 0.279 0.143 0.152 -0.105 -0.509* -0.325 
Monounsaturated Fat (g) -0.195 0.237 0.020 0.284 -0.195 0.092 
Polyunsaturated Fat (g) -0.278 0.071 0.043 0.133 -0.228 0.181 
Trans Fat (g) -0.179 0.004 -0.165 0.155 0.225 -0.112 
Cholesterol (mg) -0.272 0.032 0.072 0.050 -0.043 -0.053 
Vitamin A (IU) -0.070 -0.130 -0.107 -0.177 0.058 -0.042 
Carotenoids (RE) 0.137 0.071 -0.164 -0.177 -0.473 -0.300 
Β-carotene (mcg) 0.086 0.122 -0.178 -0.235 -0.416 -0.224 
Vitamin C (mg) 0.063 0.089 0.004 -0.060 -0.420 -0.490* 
Vitamin D (IU) -0.197 0.183 0.455 0.282 0.119 -0.181 
Vitamin E (mg) 0.023 -0.357 -0.156 0.003 0.367 -0.285 
Copper (mg) 0.203 -0.492* -0.082 -0.215 0.185 -0.335 
Iron (mg) 0.153 -0.167 0.152 0.227 -0.175 -0.274 
Zinc (mg) -0.085 -0.163 0.108 -0.021 0.123 -0.309 
Omega-3 PUFA (g) -0.184 0.115 -0.178 0.199 0.346 0.004 
Omega-6 PUFA (g) -0.063 -0.058 -0.100 0.127 0.294 0.019 
1 Values expressed in r-values 
*p<0.05 
Bold values indicate possible trend 
 
(kcal) = kilocalories; (g) = grams; (mg) = milligrams; (IU) = International Units; (RE) = Retinol 
Equivalents; (mcg) = micrograms; (IL-6) = Interleukin-6, (IL-1β) = Interleukin-1 beta, (MMP-3) 










Table 10. Pearson’s Correlation1 
Biochemical Data vs. Pain Scores and Quality of Life Assessments 
(n=17) 
 









CRP  (mg/L) 0.316 0.055 -0.315 0.227 0.211 0.240 
IL-6 (pg/mL) -0.064 -0.109 0.193 -0.234 -0.096 -0.176 
IL-1β (pg/mL) 0.099 0.428 -0.016 0.135 -0.140 -0.013 
Nitrite (µM) 0.202 0.176 -0.161 -0.108 -0.364 -0.269 
MMP-3 (ng/mL) 0.050 -0.319 -0.140 -0.299 -0.337 -0.352 
MMP-8 (ng/mL) 0.129 0.027 0.018 -0.160 0.128 -0.006 
1 Values expressed in r-values 
*p<0.05 
Bold values indicate possible trends 
 
(HAQ-DI) = Health assessment questionnaire disability index; (ICOAP) = Measure of 
intermittent and constant osteoarthritis pain; (VAS) = Visual analog scale; (mg/L) = milligrams 
per liter; (pg/mL) = pictograms per milliliter; (ng/mL) = nanograms per milliliter; (µM) = 
micromolar; (MMP) = Matrix Metalloproteinase; (IL-6) = Intereukin-6; (IL-1β) = Interleukin-1 



















Table 11. Serum Biomarkers of Cartilage Degradation Following Strawberry and Control 
Intervention 
(n=17) 






MMP-3 (ng/mL) 6.9±0.6 5.3±0.5* 7.1±0.6 6.8±0.5 
MMP-8 (ng/mL) 1.8±0.3 2.2±0.3 2.4±0.2 2.1±0.2 
Nitrite (µM) 6.4±0.7 9.9±2.2 6.4±0.8 7.5±0.8 
*p<0.05 vs. control 













Overall, our study identified several important relationships of dietary nutrient intakes 
with serum markers of inflammation and cartilage degradation in participants with symptomatic 
knee OA. Using baseline data, we identified inverse relationships of macro and micronutrients, 
such as fiber, saturated fat, total sugar, vitamin C, and copper with biomarkers of inflammation 
and cartilage degradation such as MMP-3, MMP-8, and IL-6. As part of our strawberry 
intervention, we found that daily consumption of 50g of freeze-dried strawberries significantly 
decreased serum concentration of MMP-3 in participants with symptomatic knee OA.  
Observational: Correlation Analyses Among Dietary Nutrient Intakes and Biomarkers of 
Pain, Inflammation, and Cartilage Degradation 
 To our knowledge, this is the first study to identify correlations between normal dietary 
intakes and serum concentrations of the cartilage degrading enzymes, MMP-3 and MMP-8. 
MMP’s are a family of cartilage degrading enzymes and can be detected at the systemic level. In 
knee OA, MMP’s, specifically MMP-3, facilitates the breakdown of articular cartilage, which 
contributes to joint space narrowing in the affected joint.56 Our study revealed that higher intakes 
of soluble fiber and saturated fat were correlated with lower serum concentrations of MMP-3. 
Additionally, our data also showed higher total sugar and vitamin C intakes were correlated with 
lower serum concentrations of MMP-8. 
41 
 
The relationship of dietary macronutrient intakes with pain and loss of articular cartilage 
has been previously studied in both the development and progression of knee OA.112,118 However, 
studies to evaluate relationships between dietary macronutrient intakes and serum biomarkers of 
inflammation and cartilage degradation in knee OA is lacking. Our findings suggest that lower 
serum concentrations of MMP-3 were correlated with higher saturated fat intake. However, these 
findings are not consistent with previous research efforts. Lu et al. identified a positive 
relationship between saturated fat intake and joint space narrowing.118 These findings suggest that 
the degradation of articular cartilage, which is facilitated by MMP’s, is seen among individuals 
with higher saturated fat intake. However, this particular study did not directly evaluate serum 
markers of cartilage degradation, specifically MMP’s, nor did it identify the sources of saturated 
fat. In our study, participants consumed approximately 13% of calories from saturated fat which 
is slightly greater than the recommended daily intake set by 2015-2020 Dietary Guidelines for 
Americans (recommending less than 10% of total calories).121 Although most of the research on 
saturated fat intake has been largely related to risk for cardiovascular disease, there appears to be 
no clear consensus on how different sources of saturated fat contribute to disease risk. Otto et al. 
revealed that saturated fat coming from dairy products was associated with lower CVD risk, 
whereas saturated fat coming from animal meat was positively associated with CVD risk.129 In 
contrast, the most recent review from the American Heart Association Presidential Advisory, 
identifies dairy saturated fat as a contributing factor to CVD.130  
Since our study focuses on the relationships of nutrients with pain scores and biological 
parameters as they relate to OA and not CVD, we must consider how each source of saturated fat 
(i.e. milk products, animal meat) provide other micro and phytonutrients. For example, along with 
saturated fat, 1% milk provides other nutrients such as protein, calcium, phosphorus, potassium, 
folate, vitamin A, and vitamin D.98 Animal meat, such as top sirloin, provides potassium, zinc, 
niacin, folate, and mono/polyunsaturated fatty acids.98 Our study did not evaluate food group 
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composition, therefore we are unable to identify the sources of saturated fat. However, it is 
possible the inverse correlation seen between saturated fat and MMP-3 is related to the added 
nutrients found dairy and animal meats versus processed foods which provide little or no 
nutritional value. We must also consider the fact that dietary nutrient intakes and serum 
concentrations of MMP’s has not been previously researched; therefore, this relationship may be 
a new finding in metabolic knee OA.   
We also identified a moderate inverse relationship of total sugar intake with serum 
concentrations of MMP-8. This finding suggests that higher total sugar intake is correlated with 
lower MMP-8 concentrations. This finding of total sugar intake, which includes both added 
sugars and natural sugars found in products such as fruits, vegetables, and grains. Among study 
participants, total sugar accounted for approximately 31% of total carbohydrates and 13% of total 
calories. Much of the literature suggest that adverse health conditions such as obesity, diabetes, 
and heart disease are associated with excessive intakes of added sugars.131 As discussed with 
saturated fat, it is important to understand the food source in which the sugar is coming from. For 
example, sugar sweetened beverages, such as soda, provide absolutely no nutrients beneficial to 
human health. Fruit, such as strawberries, provide fiber, vitamin C, folate, carotenoids, and 
phytochemicals, such as polyphenols.98,99,111 Given that individual food items were not 
specifically analyzed for each participant, we are unable to speculate as to whether total sugars 
accounted for added or natural sugar. It is possible that the inverse correlation seen between total 
sugar and serum concentrations of MMP-8 is related to the added nutrients found in fruits, 
vegetables, and whole grains versus added sugars. Finally, as stated with saturated fat intake, we 
must consider the fact that since these relationships have not been previously researched; this 




 In addition to macronutrient consumption, micronutrient consumption has also been well 
studied in knee OA. One of the earliest epidemiological studies in knee OA identified the 
relationship between knee OA risk and dietary intakes of vitamin C, vitamin E, and β-carotene, 
suggesting lower consumption of these vitamins was associated with an increased risk of 
developing knee OA.95,116 In our study, there was a statistically significant moderate inverse 
correlation of vitamin C intake with MMP-8. In addition, our adjusted model (n=15) also showed 
statistical trends which suggest higher intakes of vitamin C, total carotenoids, and β-carotene are 
associated with lower MMP-3 concentrations. Vitamin C and carotenoids (including β-carotene) 
are potent antioxidants found naturally in fruits and vegetables. Vitamin C is necessary for the 
homeostatic mechanism in the glutathione peroxidase cycle, which is responsible for scavenging 
lipid radicals. In addition, carotenoids, such as β-carotene, are also necessary for scavenging free 
radicals and maintaining the redox balance in the body. The disruption in the redox balance 
results from over-production of ROS and RNS and can occur in the serum and synovial fluid in 
knee OA. ROS have the ability to independently upregulate the gene expression and production 
of MMP’s.122 Therefore, it is very possible that higher consumption of these vitamins may have a 
possible mechanism which involves reducing oxidative stress to decrease the activation of both 
MMP-3 and MMP-8.    
Next, the moderate inverse relationship seen between soluble fiber intake and serum 
MMP-3 suggest that MMP-3 concentrations tend to be lower individuals with higher soluble fiber 
intake. However, it is important to understand this correlation was only seen among soluble fiber, 
not total fiber. Additionally, in our study, soluble fiber accounted for approximately 5% of the 
total fiber among the participants, with the average total fiber intake being approximately 17 
grams per day. Human studies have identified the beneficial role of soluble fiber and its ability to 
improve lipid profiles, reduce risk of CVD, improve glycemic control, and aid in weight loss.55 In 
addition, Ma et al. conducted a long-term epidemiological study and identified an inverse 
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relationship between soluble fiber and serum CRP.120 These associations were not seen in our 
study which may be due to the difference in baseline data for both total soluble fiber intake and 
serum CRP. It is possible that if soluble fiber intake had been higher among our study 
participants, we may have not only seen an inverse relationship among CRP, but also with other 
inflammatory biomarkers. It is possible soluble fiber, with many benefits to human health, may 
have the ability to reduce the overall inflammatory burden, thus resulting in lower production of 
MMP’s.  
Finally, we identified an inverse correlation between dietary copper intake and serum 
concentrations of IL-6. Copper is an essential co-factor needed for many important enzymes 
systems such as ceruloplasmin, superoxide dismutase (SOD), cytochrome oxidase.132 However, 
evidence to support the relationship of dietary copper intakes with biomarkers of inflammation 
and oxidative stress is lacking. Much of the literature identifies the impact of serum copper 
concentrations and the clinical implications associated with deficiency and toxicity. It has been 
speculated that copper has both antioxidant and pro-oxidant capabilities which are largely related 
to the production of ROS due to decreased SOD activity (copper deficiency) and increased 
Fenton reactions (copper toxicity).132,133 Bo et al. identified higher serum hs-CRP concentrations 
among participants with higher dietary copper intakes. Although this study did not directly 
evaluate serum IL-6 concentrations, they hypothesize that higher inflammation may be a result of 
higher dietary copper intakes, higher serum copper concentrations, and increased oxidative 
stress.134 In our study, average dietary intake of copper among participants fell well short of the 
RDA and that of the previously mentioned study (1.5mg/day, Bo et al.).52,134 Since our study did 
not evaluate serum copper concentrations, it would be difficult to speculate the specific 
mechanism behind the inverse relationship of copper with IL-6. It is possible this is a new finding 
in metabolic knee OA. However, future studies would need to be conducted to determine the 
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influence of dietary copper intakes with both serum copper concentrations and IL-6 
concentrations in participants with knee OA. 
It is important to address why there were no statistically significant correlations identified 
among dietary nutrient intakes with pain scores and quality of life indicators; as well as among all 
biochemical parameters with pain scores and quality of life indicators. In 2014, Choi et al. 
conducted an ecological momentary study to evaluate the relationship between pain and eating 
among individuals with symptomatic knee OA. The researchers concluded the relationship 
between dietary intakes and pain is cyclic; where higher pain yields higher energy intakes 
(specifically in the form of total fat and total sugar), and higher energy intakes, further perpetuate 
pain in knee OA.112 Additionally, other studies have identified that higher energy intakes, total 
carbohydrate intakes, and total sugar intakes are positively correlated with the development of 
BML’s in knee OA.97 The development of BML’s have also been associated with higher pain 
levels among individuals with symptomatic knee OA.135 The findings from these previous studies 
lead us to hypothesize that higher dietary intakes of total fat and total carbohydrate would be 
positively correlated with pain scores and biochemical parameters, and inversely correlated with 
quality of life indicators. These findings were not identified in our unadjusted analysis (n=17). 
However, we did identify several statistically significant correlations in our adjusted model 
(n=15), suggesting an inverse correlation of total cholesterol intake with HAQ-DI and total 
carbohydrate intake with ICOAP: constant pain. At baseline, participants reported having only 
mild to moderate pain, as indicated in VAS and ICOAP questionnaires; as well as only mild to 
moderate difficulty performing daily tasked, indicated by HAQ-DI questionnaires. Had our 
participants reported moderate to severe pain, moderate to severe difficulty with daily tasks, or 
had different dietary patterns, we may have identified statistically significant correlations among 
these variables in our unadjusted model. The fact that we did identify two statistically significant 
correlations in our adjusted model, leads us to suspect that there is an important relationship that 
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exists between dietary nutrient intakes and pain scores or quality of life indicators, which should 
be confirmed in a fully powered study.   
Although not statistically significant, we did identify one trend in our unadjusted model 
suggesting a possible positive correlation of soluble fiber intake with ICOAP: constant pain 
percent. This suggests that higher soluble fiber intakes trended toward being positively 
correlation with higher pain scores for this assessment. This trend is contrary to previous research 
conducted by Dai et al. who identified that higher total fiber intakes (amounts equal to 25g per 
day), was associated with lower WOMAC pain scores among participants with symptomatic knee 
OA.115 Based on these findings we anticipated an inverse correlation of total fiber intake with 
pain scores and a positive correlation with quality of life assessments. However, these 
expectations were not met. As stated previously, participant’s total fiber intake fell well short of 
the recommended 25g for women and 38g for men.52 Therefore, it is possible we did not identify 
the anticipated correlations due to low fiber intake among our study participants, or due to our 
participants reporting having only mild to moderate pain, and mild to moderate difficulty with 
daily tasks. 
Lastly, our findings did not reveal any statistically significant correlations of biochemical 
parameters (serum concentrations of CRP, IL-6, IL-1β, nitrite, MMP-3, and MMP-8) with pain 
scores or quality of life assessments among study participants at baseline in our unadjusted 
model. We hypothesized that higher serum concentrations of these biomarkers would be 
positively correlated with pain scores, and inversely correlated with quality of life indicators. 
Two studies have identified a positive relationship between serum concentrations of 
inflammatory biomarkers and OA pain. Strurmer et al. found that participants with symptomatic 
hip or knee OA, had a 5.7% increase in serum hs-CRP concentrations for every 10mm increase in 
VAS pain scores.105 Similarly, Stannus et al. also identified positive associations of hs-CRP, 
TNF-α, and IL-6 with WOMAC pain scores at baseline or after a 2.7 year follow-up.106   The 
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findings from these previous studies were not confirmed in our study participants. Comparatively, 
our participants reported having less pain and presented with much higher baseline concentrations 
of hs-CRP and IL-6. However, although not statistically significant, we did identify a positive 
trend among IL-1β and VAS pain scores in our unadjusted model. This trend suggested that 
higher IL-1β concentrations may be positively correlated with higher VAS pain scores. Although 
the overall findings among these particular variables was not as expected, this trend proposes 
there may be some sort of positive relationship between inflammatory biomarkers and pain scores 
and should be confirmed in a full powered study.      
 Intervention: Effects of Freeze-Dried Strawberries on Biomarkers of Cartilage 
Degradation  
 To our knowledge, this is the first human study to report the impact of the polyphenol-
rich strawberry supplementation on biomarkers of cartilage degradation in knee OA. Most of the 
current research investigating the impact of phytochemicals on MMP-3 concentrations have been 
conducted in cell and animal studies. Curcumin has been widely studied in OA and has shown to 
decrease in IL-1β stimulated human chondrocytes, and reduce the mRNA expression of MMP-3 
in C57BL/6 mice.44,90 In addition, in-vitro studies evaluating ASU have also seen a decrease in 
MMP-3 with and without IL-1β stimulation.41 Lastly, green tea catechins have also shown to 
reduce MMP-3 in the articular cartilage of C57BL/6 mice.91 However, very few studies have 
evaluated the effects of polyphenols and nutraceuticals on serum levels of MMP’s in humans. 
Mirtaheri et al. evaluated the effects of alpha-lipoic acid on serum concentrations of MMP-3 in 
participants with rheumatoid arthritis, but found no significant changes after an 8 week 
intervention.54 Additionally, Goochani et al. showed that the polyphenolic rich pomegranate was 




 One important mechanism to consider when evaluating the results of our study is the 
impact the strawberry intervention had on biomarkers of inflammation. MMP-3 is greatly 
influenced by inflammatory cytokines such as IL-1β.27,56Although beyond the scope of this paper, 
our study also measured serum levels of IL-6 and IL-1β, which  significantly decreased after 
strawberry intervention.123 It is important to consider that this decrease in MMP-3 may also be a 
result of the reduction in these pro-inflammatory cytokines. Other clinical studies examining the 
effects of strawberries have identified their ability to significantly reduce lipid peroxidation, 
increase endogenous antioxidant enzymes, and reduce oxidative bi-products such as MDA and 
hydroxnonenol (HNE).49,100,101 Therefore, one proposed mechanism of action, could be that 
strawberries reduce overall oxidative stress and decreasing the inflammatory burden, thus 
reducing the activation of cartilage degrading enzymes, such as MMP-3.  
It is also important to address why similar effects were not seen for serum nitrite and 
MMP-8. Nitrite is a byproduct of the effector molecule NOx which spontaneously breakdowns 
down into nitrate and nitrite.124 The production of NOx is facilitated by three forms on nitric 
oxide synthase; eNOS, which is important in endothelial vasodilation, iNOS, which can trigger 
inflammation and tissue destruction, and nNOS, which is important in cell signaling.59,125 Our 
study showed a small but insignificant increase in serum nitrite levels after strawberry 
supplementation. Although nitric oxide synthase gene expression was not assessed in this study, it 
is possible that the polyphenol rich berry had an effect on increasing gene expression of eNOS 
resulting in an increase in NOx production. This proposed mechanism has been addressed in-vitro 
by Lazzé et al. and Xu et al. who have shown the ability of anthocynains to upregulate gene 
expression of eNOS in human and bovine endothelial cells.126,127 In addition to serum nitrite, the 
null effects of strawberry intervention on serum concentrations of MMP-8 were also observed in 
our study. Although MMP-8 has been identified as a culprit in human articular cartilage 
degradation in-vitro, to date, no study has been reported on the effects of polyphenol intervention 
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on serum concentrations of this enzyme in humans with OA.128 It is possible that in metabolic 
OA, serum concentrations of MMP-8 may not be modulated by polyphenols. It is also possible 
the dose of strawberries was not large enough to modulate a response, or that our sample size was 
simply too small to identify changes in MMP-8 after strawberry intervention. Future research 
should be conducted in larger clinical trials to identify if polyphenol intervention has an effect on 
serum concentration of MMP-8 in participants with knee OA..  
Strengths, Limitations, and Future Research 
 The most significant limitation to our study is the small sample size of our pilot study 
(n=17). Therefore, it may be difficult to generalize the findings presented in this study to a larger 
population. Future research efforts should attempt to perform a fully powered study with a large 
sample size to confirm and strengthen our findings. Another limitation to this study is the cross-
sectional design, which only evaluates participants with a previously diagnosed knee OA. 
Although the study provided us with valuable insight into the relationship between dietary habits, 
pain, and inflammation, future research should include longitudinal epidemiological data to 
assess how dietary intake impact the development of this chronic condition. Additionally, future 
observational studies may want to assess food group composition to better understand sources of 
nutrients. In doing so, this may provide further insight into protective dietary patterns in knee OA. 
Another potential limitation is the study lacks a dose-response design to evaluate the optimal 
serving of strawberries that have an effect on serum biomarkers of inflammation and cartilage 
degradation. Our participants consumed 50 grams per day of freeze-dried strawberries and 
placebo powder each for 12 weeks. It is possible that alternative dosages, whether smaller or 
larger, may modulate a more desirable outcome and better reflect common eating patterns.  
 Our study does have several strengths as well. First, by using three-day food records 
collected at baseline, we were able to get a better understanding of each participant’s common 
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dietary patterns. Compared to 24-hour recalls, three-day food records allowed us to take an 
average of macro and micronutrients over several days which is more likely to reflect their 
normal diet. Next, by collecting three-day food records at each visit (baseline, end of phase 1, end 
of washout, and end of phase 2), we were able to confirm that participants did not change dietary 
habits throughout the duration of the study. Therefore, we believe the changes in these 
biochemical parameters were a result of the strawberry intervention rather than habitual dietary 
changes. Finally, the cross-over design of our intervention phase allowed each participant to serve 
as his or her own control, eliminating confounding variables. Additionally, each arm of the study 
accounted for a substantial amount of time in either the intervention or treatment group (12 weeks 
in each, 24 weeks total), allowing ample time for the bioactive components to facilitate a desired 
effect, with the two-week wash out period minimizing the potential for a carry-over effect.  
Conclusion 
Not only are the number of individuals with symptomatic knee OA increasing in the U.S., 
the condition is becoming more prevalent in a younger population given the obesity epidemic.94 
The majority of treatment strategies focus on pain management with pharmaceuticals and weight 
loss to decrease adiposity and the mechanical loading of the knee joint. The overall goal of any 
treatment strategy in knee OA should focus on reducing the chronic inflammatory burden 
associated with metabolic knee OA. In doing so, this may aim to not only reduce pain, but 
suppress the cartilage degrading enzymes that further contribute to the progression of this 
condition. 
In our study, lower serum concentrations of cartilage degrading enzymes were seen 
among higher intakes of soluble fiber, total sugar, saturated fat, and higher vitamin C. Although 
our study does not identify cause and effect, it provides insight into the relationship between food 
intake and disease characteristics. We can conclude that a well-balance diet which includes 
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adequate intakes of saturated fat, total sugar, soluble fiber, vitamin C, carotenoids, and copper 
may be protective against the activation of cartilage degrading enzymes in symptomatic knee OA.  
We also showed that freeze-dried strawberry intervention significantly decreased serum 
concentrations of MMP-3 compared to the placebo. Based on the findings from our pilot study, 
strawberry supplementation as a therapeutic intervention is not recommended. However, as an 
adjunct therapy, strawberry supplementation may have an implication in knee OA. Dietary habits 
in the management of knee OA symptoms and biological parameters should focus on 
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